Excimer laser for revascularisation of saphenous vein grafts

Lasers in Medical Science

Volumn 16, Issue 2, 2001, Pages 78-83

  Ebersole, D G ^a  

^a Watson Clinic   (United States)

Author keywords

Balloon angioplasty; Excimer laser angioplasty; Ischemia; Saphenous vein grafts; Thrombus

Indexed keywords

ARTICLE; ATHERECTOMY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORONARY STENT; EMBOLISM; EXCIMER LASER; HEART INFARCTION; HUMAN; LASER ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; SAPHENOUS VEIN GRAFT;

EID: 0035024866     PISSN: 02688921     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00011346     Document Type: Article

References (45)

1. Longterm fate of bypass grafts. The Coronary Artery Surgery Study (CASS) and Montreal Heart Institute experiences
2. Treatment of chronic stable angina. A preliminary report of survival data of the randomized veterans administration cooperative study
3. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy: Results of a veterans administration cooperative study
4. Progression of atherosclerosis in coronary arteries and bypass grafts: Ten years later
5. Reoperation for coronary atherosclerosis
6. Incidence of repeat revascularization after coronary bypass surgery
7. Percutaneous transluminal coronary angioplasy in patients with prior coronary bypass surgery
8. Percutaneous transluminal coronary angioplasty in patients with prior coronary artery bypass grafting
9. Percutaneous transluminal angioplasty of stenosed aortocoronary bypass grafts
10. Percutaneous angioplasty of stenoses of bypass grafts or of bypass graft anastomotic sites
11. Percutaneous transluminal coronary angioplasty after previous coronary artery bypass surgery
12. Percutaneous transluminal angioplasty in aortocoronary venous graft stenoses: Immediate results and complications
13. Percutaneous transluminal angioplasty of stenotic coronary artery bypass grafts: 5 years experience
14. Percutaneous transluminal angioplasty at saphenous vein graft: Long-term follow-up
15. Directional coronary atherectomy of saphenous vein graft narrowings: Multicenter investigational experience
16. Acute and long-term outcome of narrowed saphenous venous grafts treated by endoluminal stenting and directional atherectomy
17. Directional atherectomy of saphenous vein graft lesions unfavorable for balloon angioplasty: Results of a single center experience
18. Directional atherectomy of saphenous vein grafts: Recent multicenter experience
19. Directional coronary atherectomy for saphenous vein graft stenoses
20. Transluminal atherectomy of saphenous vein aortocoronary bypass grafts
21. A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions
22. Mechanism of transluminal extraction catheter (TEC) atherectomy in degenerative spahenous vein grafts (SVG): An angioscopic observational study
23. Mechanical dilatation rather than plaque removal as major mechanism of transluminal extraction atherectomy
24. Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts
25. Transluminal extraction catheter for the treatment of diseased saphenous vein grafts. A multicenter experience
26. Acute results and long-term outcome of transluminal catheter atherectomy for saphenous vein graft stenoses
27. Favorable results of debulking followed by immediate adjunct stent therapy for high risk saphenous vein graft lesions
28. Stenting of all venous bypass grafts: A new treatment modality for patients who are poor candidates for reintervention
29. Stenosis of aortocoronary venous bypass grafts
30. Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts
31. A randomized trial of coronary stenting and balloon angioplasty in the treatment of aortocoronary saphenous vein bypass graft disease
32. Interim report from the reduced anticoagulation vein graft stent (RAVES) study
33. The physical and biological basis for laser angioplasty
34. Whose fault is it? Notes on 'true' versus 'pseudo' laser failure
35. Coronary artery perforation during excimer laser coronary angioplasty
36. Clinical results with excimer laser coronary angioplasty
37. Percutaneous excimer laser coronary angioplasty: Results in the first consecutive 3000 patients
38. Effect of intracoronary saline infusion on dissection during excimer laser coronary angioplasty: A randomized trial
39. Predictors of outcome of percutaneous excimer laser coronary angioplasty of saphenous vein bypass lesions
40. Length of hospital stay and complications after percutaneous transluminal coronary angioplasty: Clinical and procedural predictors
41. Six-month results of debulking followed by immediate stent therapy for high risk saphenous vein graft lesions
42. Use of a monoclonal antibody directed against the platelet glycoprotein IIB/IIa receptor in high-risk coronary angioplasty
43. Randomized trial of coronary intervention with antibody against platelet IIb/IIIa integrin for reduction of clinical restenosis: Results at six months
44. Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology